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Introduction
Despite advances in prophylaxis, diagnostic modalities,
and therapeutic options, pulmonary embolism (PE) remains a
commonly underdiagnosed and potentially lethal entity.
Studies have estimated an annual incidence of over 600,000
cases of PE in the US with a related mortality of almost
200,000 deaths.1According to various autopsy series, the ante
mortem diagnosis of pulmonary embolism (made in only 30%
of cases) and the PE related mortality either directly or
indirectly has not improved over the last four decades.2,3 PE
related mortality ranges from 4.1% in haemodynamically
stable patients to 31% for those patients presenting with
massive pulmonary embolism.4
Major  pulmonary embolism (MPE) is defined as an
embolus on spiral CT scan involving either the main
pulmonary trunk or the ascending or descending branches of
right and left pulmonary arteries or both along with either
hypotension due to the embolus (massive PE) or evidence of
right ventricular dysfunction on echocardiography without
hypotension (sub massive PE).5
Pulmonary embolism in Pakistan remains largely
unrecognized, underdiagnosed and undertreated clinical
problem amongst hospitalized patients due to non-availability
of objective tests and lack of awareness among physicians.
There are very few reports available from Pakistan on
pulmonary embolism and in fact there is no data on major
pulmonary embolism. 
We conducted this study to evaluate the clinical
features, management strategies and outcome of major
pulmonary embolism (MPE) in a tertiary care center of
Karachi. 
Material and Methods
A retrospective chart review of all hospitalized patients
who had a spiral CT of the chest done for suspected pulmonary
embolism between January 2000 and June 2007 at Aga Khan
University Hospital was done using a computerized database. 
Patients who fulfilled the criteria of major pulmonary
embolism anatomically ie pulmonary emboli in the main
pulmonary trunk or the ascending or descending branches of
main pulmonary arteries with or without hypotension were
selected.  All others were excluded from our study.
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Abstract
Objective: To evaluate the clinical characteristics, risk factors, management and outcome of major pulmonary
embolism (PE) in a tertiary care center of Karachi. 
Methods: Medical records of all patients who underwent a spiral CT scan of the chest for suspected pulmonary
embolism were reviewed between January 2000 and June 2007 at the Aga Khan University Hospital, Karachi.
Patients having evidence of major pulmonary embolism on spiral CT scan were selected.
Results: A total of 30 patients (10 males, 20 females) with mean age 52 ± 14.59 years were identified who
fulfilled our predefined criteria for major pulmonary embolism. Risk factors for thromboembolism were identified
in 22 (73%) patients, prolonged immobilization in 8 (27%) and recent surgery in 8 (27%) patients being the
commonest. All patients were symptomatic on presentation. Tachypnea and tachycardia were present in 27
(90%) patients. Refractory hypoxia was present in 18 (60%) patients and 3 (10%) were hypotensive on
presentation. On spiral CT scan, 8 (27%) patients had embolus in the main pulmonary trunk, 26 (87%) patients
in main right pulmonary artery and 20 (67%) patients had left main pulmonary artery embolus. Echocardiography
was done in 22 (73%) patients with the findings of right ventricular dysfunction in all of them. All patients except
one were treated with anticoagulation with either heparin infusion or low molecular weight heparin. In addition,
thrombolytics were given in 7 (23%) patients and five (17%) underwent surgical embolectomy. Four (13%)
patients died during hospitalization with a total of 26 (87%) surviving till hospital discharge.
Conclusion: Major pulmonary embolism is an uncommon but potentially life threatening entity. Early diagnosis
and aggressive therapy improves the clinical outcome (JPMA 59:372; 2009).
Data on demographics, clinical features,
radiographs, echocardiography, management and outcome
was collected.
The Statistical package for social science SPSS
version 11 was used for data analysis. The descriptive
analysis was done for demographic, clinical, radiographic
features and laboratory results. Results were expressed as
mean ± standard deviation, and number (percentage).
Results
A total of 30 patients were identified over the study
period that met our predefined criteria of major pulmonary
embolism. The mean age was 52 ± 14.59 years (range 23-
75 years). Risk factors for thromboembolism were
identified in 22 patients (73%), immobilization and recent
surgery as the commonest recognized factors. Other
important risk factors included previous history of Deep
Vein Trocombosis (DVT), trauma and hypercoagulable
state. Details of the demographics and risk factors are
presented in Table. 
All patients were symptomatic, with dyspnoea and
tachycardia present in 27 (90%), 9 (30%) presented with chest
pain and 2 (7%) with haemoptysis. Twenty patients (67%)
were hypoxic and 3 (10%) were hypotensive on presentation. 
Arterial blood gases (ABG) were done in 27 patients
(90%).  Respiratory alkalosis (pH >7.45, PaCO2 < 35 mmHg)
was the commonest finding, present in 26 patients (86%).
Refractory hypoxia was present in 18 (60%) patients.  D-dimer
assay was tested in 17 (57%) patients, being positive (value >
0.5) in 9 patients (30%) only.
The chest radiograph was abnormal in 20 (67%)
patients with cardiomegaly as the commonest finding (33%,
10 patients). Other features included pleural effusion in 9
(30%), atelectasis in 8(27%), enlarged pulmonary artery in
7 (23%), focal oligaemia in 6 (20%) and elevated hemi
diaphragm in 4 (13%).
All patients underwent spiral CT chest. The embolus
was visualized in the main pulmonary trunk in 8 (27%)
patients, in the proximal right pulmonary artery in 26 (87%)
patients and in the left pulmonary artery in 20 (67%) patients.
Four (13%) patients were noted to have pulmonary infarction
and 10 (33%) patients showed concomitant thrombus in the
deep veins of the extremities.
Echocardiography was done in 22 (73%) patients with
evidence of right ventricular dysfunction in all of them. Right
ventricular (RV) hypokinesis was present in 16 (72%) patients,
right ventricular dilatation in 16 (72%) patients, tricuspid
regurgitation in 18 (82%) patients, severe pulmonary
hypertension in 10 (46%) patients and paradoxical
interventricular septal shift in 6 (27%) patients.
All patients except one (95%) received anticoagulation
with either intravenous heparin or subcutaneous low
molecular weight heparin (LMWH, Enoxaparin).  In addition
intravenous thrombolytics (streptokinase) were given in 7
(23%) patients, five (17%) patients underwent surgical
embolectomy and five (17%) patients had inferior vena cava
filter placement. Three (10%) patients required mechanical
ventilation for respiratory failure. 
Four (13%) patients died due to refractory shock and
hypoxia. One patient had arrived in the ER with severe shock
and hypoxia and received intravenous streptokinase but did not
survive; in the other three patients only subcutaneous low
molecular weight heparin was used. Twenty six (87%) patients
survived and were discharge from the hospital. 
Discussion
Traditionally major pulmonary embolism has been
defined on anatomical grounds, as a greater than 50%
obstruction of the pulmonary vasculature or the occlusion of
two or more lobar pulmonary arteries. However, recently the
term "massive PE" is being used based not only on the size of
the embolus but also on the underlying cardio-respiratory
status, such that the net effect results in haemodynamic
instability.6,7
In our group we included all patients who had
anatomically major PE even in the absence of hypotension on
presentation. The group of patients with haemodynamically
stable PE along with evidence of right ventricular dysfunction
on 2D echocardiography has shown in numerous studies to
have a much higher mortality compared to those without it.7A
term of "submassive PE" has been coined to categorize this
group. These patients require closer and more aggressive
management due to high potential for deterioration and
subsequent poorer outcome.7 Our cohort included only three
patients with hypotension on presentation (massive PE), the
rest (90%) were haemodynamically stable (submassive PE).
Also, in our cohort the commonest clinical presentation was of
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Table:  Demographics and risk factors of massive PE patients.
Demographics Number (%)
Total no. of patients 30
Sex:
Male 10 (33%)
Female 20 (67%)
Age:
Mean (Range) years 52 (23-75)
Risk factors:
Prolonged bed rest / immobilization 22 (73 %)
Recent surgery (past 3 months) 08 (27 %) 
Trauma 08 (27 %)
Previous DVT 04 (13 %)
Hyper coagulable state 07 (23 %)
Malignancy 06 (20 %)
dyspnea, tachycardia (90% each) and chest pain (28%) which
is consistent with other studies.8
Despite the vast array of physiological abnormalities
associated with PE, hypoxia is not a uniform finding.9,10 In our
study hypoxia was documented in 71% of patients only. Part of
the reason could be that most patients who present with
breathlessness and tachycardia are generally placed on
supplemental oxygen before checking their pulse oximetry or
arterial blood gases.  
On ABG analysis 86% of patients had respiratory
alkalosis (pH >7.45 & PaCO2<35 mmHg) which is due to the
tachypnea resulting from the sudden occlusion of the
pulmonary arterioles by the thromboembolism.11
Spiral CT scan of chest has been considered a very
good diagnostic tool due to its availability, noninvasiveness,
rapidity and accurate results. Some studies have shown
sensitivity and specificity in excess of 90% for proximal PE.12-
14 This has replaced ventilation perfusion scan due to its better
sensitivity and specificity and also because it can give evidence
of an alternate diagnosis if present. Studies have also suggested
that this modality should replace pulmonary angiogram as a
gold standard for the diagnosis of PE, particularly due to the
invasiveness and the morbidity of the latter.15However, a word
of caution; spiral CT can miss significant number of smaller
peripheral emboli. In our institution the spiral CT has replaced
the pulmonary angiogram as the diagnostic procedure of
choice for PE.
Transthoracic echocardiography is of tremendous value
in the setting of major pulmonary emboli, due to its ability to
diagnose the severity and impact of the embolism and response
to therapy.16 In addition it is widely available, reproducible,
and non-invasive. It also may detect emboli in transit or
suggest alternative diagnosis. Echocardiographic findings in
patients with MPE are signs of right ventricular pressure
overload which include right ventricular dilatation, pulmonary
artery dilatation paradoxical septal motion, right ventricular
hypokinesis and tricuspid regurgitation.17 Of our patients 73%
had echocardiography done and all of them had signs of right
ventricular dysfunction (100% sensitivity).
Anticoagulation with heparin should be initiated in the
absence of contraindication, once the diagnosis of PE is
considered. Early and adequate anticoagulation has shown to
decrease mortality.18 Subcutaneous low molecular weight
heparin can be used as an alternative to intravenous heparin,
however the experience is limited in the setting of massive PE. 
Thrombolytic therapy for MPE has been studied
extensively. When assessed by angiography, perfusion scans
and echocardiography; thrombolytics have shown to
produce more rapid clot lysis as compared to heparin
therapy alone.19,20 This however, has not shown to
significantly alter the outcome of such patients.
Thrombolytic therapy is uniformly acknowledged as the
treatment of choice for haemodynamically unstable
patients. In case of submassive PE the data is less clear.
Recently, two studies of submassive pulmonary embolism
have shown a mortality advantage and reduced incidence of
recurrent venous thromboembolism with intravenous
thrombolytics.21,22 Among the seven patients that received
thrombolytics in our cohort, only one patient died and there
were no bleeding complications.
Surgical embolectomy is generally reserved for patients
with refractory shock despite aggressive medical therapy,
ongoing cardiac arrest, or patients with contraindications to
thrombolytics.23-25 Recently a single center experience with
massive PE without shock had a 86% survival at one year.25All
five of our patients who underwent surgical embolectomy
survived till discharge. Catheter thrombectomy is especially
useful in the presence of an increased bleeding risk or if
surgical embolectomy is not an option.      
New catheter devices have broadened the role of this
approach in the management of major pulmonary
embolism.26-28
In our cohort all patients were started on treatment once
the diagnosis was suspected. Anticoagulation was initiated on
95% of our patients with either heparin infusion or low
molecular weight heparin. Five (17%) of our patients
underwent surgical embolectomy and seven (23%) received
intravenous thrombolytics. The indications for intravenous
thrombolytics and  surgical embolectomy included shock and
refractory hypoxia.   
Four patients (13%) died due to refractory shock and
hypoxia. One patient had arrived in the ER with shock and
received thrombolytics in the ER but did not improve; in the
other two patients only subcutaneous low molecular heparin
was used. In all 26 (87%) patients survived to discharge from
the hospital. Our cohort had only confirmed cases of large
pulmonary emboli, based on spiral CT findings. This is
probably why mortality in our cohort is very low. We may have
missed cases that were not diagnosed antemortem.
In our institution we follow an algorithm for major PE,
which includes an urgent bedside echocardiogram and a spiral
CT scan. A pulmonary angiogram is very rarely required.
Anticoagulation is initiated as soon as PE is clinically
suspected if there is no contraindication to it. Thrombolytics
and surgical embolectomy are considered in patients presenting
with shock and in those with refractory hypoxia.
The limitations of the study were the retrospective
charts review so the complete data of all patients were not
available. The rationale for giving thrombolytics was not
uniform and was dependent on physician discretion.
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Conclusion
In conclusion, we need to maintain a high degree of
clinical suspicion for major pulmonary embolism in patients
presenting with shock and/or refractory hypoxia or
unexplained tachypnea and tachycardia. 2D echocardiography
is a good tool which assists in the diagnosis of major
pulmonary embolism with an excellent sensitivity. Once
diagnosed, early and aggressive management can result in
good survival.
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